FDA Panel Takes ‘Leap Of Faith’ In Backing Epinephrine Nasal Spray For Anaphylaxis

 
• By Brenda Sandburg
epinephrine
FDA advisory panel finds PK/PD data supports favorable assessment of intranasal epinephrine for treatment of anaphylaxis • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers